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Previewsand enrich tissue-specific progenitors
which may prove to be MSC-like cells.
Such reagents have the potential to accel-
erate the pace for the translation of MSC-
like cells to the clinic, as well as to
advance our understanding of their basic
science at the mechanistic level. Addi-
tionally, phage display may yield peptides
suitable for targeted manipulation and/or
selective homing of MSC-like cells
in situ. Indeed, Kolonin and colleagues
have employed such approaches to
selectively ablate adipose tissue in vivo
(Kolonin et al., 2004).
While resistin has been studied for over
a decade, its receptor and signal trans-
duction mechanism remains an active
area of investigation (Schwartz and Lazar,
2011). Few studies have reported
evidence of a resistin receptor (Schwartz
and Lazar, 2011). The current work
provides novel evidence that resistin
interacts directly with decorin. It remains
to be seen if and how decorin mediates
resistin signal transduction in multiple
tissues. Of course, there are always
caveats. For example, there are species-
specific differences in the expression
and functionality of resistin (Schwartz
and Lazar, 2011). While resistin is associ-2 Cell Stem Cell 9, July 8, 2011 ª2011 Elseviatedwith adipocytes in themouse, human
macrophagesalso express this protein, so
the biology of the WAT7/decorin interac-
tion in the mouse may not mimic that in
man (Schwartz and Lazar, 2011). Still,
such minor points should not detract
from the bigger story, namely, that phage
display methods have emerged as an
unbiased in vivo discovery tool for the
characterization and identification of
novel surface markers and signal trans-
duction pathways for stem cells. This
method has the potential to shed new light
on our understanding of how stem cells in
solid organs interact with their microenvi-
ronmental niche in situ. The next challenge
will be for other stem cell laboratories to
reproduce and expand on the UT-Hous-
ton team’s exciting approach.
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The molecular mechanisms specifying hematopoietic stem cells (HSCs) in the vertebrate embryo remain
poorly understood. Recently in Nature, Traver and colleagues demonstrate that timed wnt to Notch relay
signaling across multiple cell types serves as an early upstream mechanism of HSC induction in zebrafish
(Clements et al., 2011).Every second of our life, millions of blood
cells have to be replaced to maintain
our blood system. All these cells are
ultimately produced from hematopoietic
stem cells (HSCs), which have the
capacity to give rise to all blood cell typesand to self-renew in order to maintain
HSC numbers life-long. Due to their fasci-
nating ability to repopulate the entire
blood system of a recipient organism
upon simple transplantation, HSCs have
successfully been used for regenerativecell therapy for decades. However, the
low number of clinically available HSCs
remains a major restriction for their appli-
cation. Novel approaches for their expan-
sion or de novo generation in vitro would
therefore have a huge clinical impact.
Figure 1. Signaling Pathways Involved in Specification of Vertebrate Definitive
Hematopoiesis
Non-cell-autonomous signaling in somites via wnt16/Notch pathways is first required before the formation
of the dorsal aorta (left). HSC specification is later induced by cell-autonomous signaling including HH/
VEGF/Notch in the ventral wall of the dorsal aorta (right). S, somite; NT, neural tube; N, notochord; DA,
dorsal aorta; CV, cardinal vein; HH, hedgehog; NL, Notch ligand.
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PreviewsHowever, despite decades of research,
HSC generation by in vitro differentiation
from pluripotent cells such as embryonic
stem cells (ESCs) or patient-specific in-
duced pluripotent stem cells, or by direct
reprogramming from somatic cells, has
not been accomplished. Improved under-
standing of HSC specification from their
embryonic progenitors therefore is not
only of highest scientific interest, but is
also a crucial prerequisite for the develop-
ment of novel therapies.
After decades-long disputes about the
cellular source of the first embryonic
blood cells, bioimaging approaches re-
cently allowed the observation of endo-
thelial cells differentiating into blood cells
at the single-cell level (Eilken et al., 2009;
Bertrand et al., 2010), demonstrating the
existence of hemogenic endothelium as
a source of embryonic hematopoiesis.
Knowledge of the cell type from which
blood originates is an important prerequi-
site for studying the involved molecular
mechanisms. However, while numerous
molecular pathways in different cell types
have been implicated in controlling blood
specification, their exact temporal andspatial integration remain poorly under-
stood (Ciau-Uitz et al., 2010; Paik and
Zon, 2010).
After analyzing embryonic hemato-
poiesis in zebrafish, Clements and col-
leagues now introduce wnt signaling as
a novel player in induction of definitive
hematopoiesis (Figure 1; Clements et al.,
2011). Zebrafish is an excellent model
system for analyzing developmental
hematopoiesis. In addition to easy in vivo
imaging of transparent embryos devel-
oping ex utero (Bertrand et al., 2010) and
the availability of very efficient genetic
tools, many required methodologies for
analyzing hematopoiesis have also been
developed for zebrafish (Paik and Zon,
2010). As in mammals, zebrafish hemato-
poiesis has two distinct waves. The
‘‘primitive’’ HSC-independent wave from
about 12 hr postfertilization (hpf) gener-
ates a transient population of differenti-
ated embryonic effector cells, such as
erythrocytes. Later, the therapeutically
relevant ‘‘definitive’’ hematopoietic cells
are generated, which maintain all blood
cells throughout adult life. Definitive HSCs
emerge at around 30 hpf from the ventralCell Stemwall of the dorsal aorta. Integration of
Hedgehog (HH), vascular endothelial
growth factor (VEGF), bone morphogenic
protein (BMP), and Notch signaling has
been shown to be involved in the genera-
tion of definitive hematopoiesis in verte-
brates (Figure 1; Cerdan and Bhatia,
2010; Ciau-Uitz et al., 2010; Paik and
Zon, 2010). Signals from these pathways
drive expression of required transcription
factors including Runx1, which is essen-
tial for the specification of the signal-
receiving cells as HSCs.
Clements and colleagues have now
identified a zebrafish wnt16 ortholog,
which is expressed at around the time
and sites of HSC specification. b-cate-
nin-independent wnt16 signaling initiates
Notch signaling by inducing expression
of the deltaC (Dlc) and deltaD (Dld)
Notch ligands. Importantly, these Dlc/
Dld-mediated Notch signals (Figure 1)
are different from the Notch signals
previously described to be involved in
the cell-autonomous HH/VEGF/Notch
signaling required for HSC specification
(Figure 1). Wnt16 signaling is required
well before the actual HSCs are specified,
and starts a cascade of signals through
different cell types including different
somite cell types, and later probably
mesenchymal cells underlying the aorta
and endothelial cells. Interestingly, both
Dlc and Dld expression are simulta-
neously required at this early step to
initiate the relay signaling cascade leading
to HSC specification.
Notch and wnt signaling pathways
control a multitude of developmental and
adult cell fate decisions (Cerdan and Bha-
tia, 2010). They are also very complex and
notoriously difficult to analyze. Due to the
many ligands and receptors with unclear
interactions, and many potential extracel-
lular and intracellular modifiers, these
pathways and their functions in controlling
cell fate remain poorly understood. For
wnt, there are twomain intracellular signal
transduction pathways, the b-catenin/
TCF/LEF-dependent and the b-catenin-
independent—usually referred to as
canonical and noncanonical pathways,
respectively. However, their clear separa-
tion, the involvement of specific ligands
and receptors, and their independence
remains disputed. The role of Notch
signaling in inducing definitive hematopoi-
esis iswell accepted. In contrast, its role in
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Previewscells remains highly controversial, with
different studies postulating an important
function in HSCs, or no role whatsoever
(Cerdan and Bhatia, 2010; Maillard et al.,
2008). The role of wnt signaling in HSCs
is equally unclear, with claims of a role in
controlling hematopoietic stem and
progenitor fates, or that it is dispensable
in HSCs (Malhotra and Kincade, 2009;
Cerdan and Bhatia, 2010). It will be inter-
esting to see if these novel insights into
the role of wnt signaling in HSC specifica-
tion can also help to clarify potential roles
in the complex niches of adult HSCs.
Although the current study includes
some indications of the cellular source of
the wnt16, precise identification of the
specific wnt16-producing cell type, and
of the molecular control of its expression,
will be necessary to comprehensively
unravel blood specification. The simulta-
neous requirement of two independent
Notch ligands is puzzling and of wide
interest. Part of the mechanisms behind
this synergy has probably just been
described in another recent publication
(Wright et al., 2011). It will be important
to determine whether the molecular
mechanism described by Traver and4 Cell Stem Cell 9, July 8, 2011 ª2011 Elsevicolleagues also functions in mammalian
development. This study very nicely
confirms and illustrates the existence of
specific, sequential windows of time at
which defined combinatorial environ-
mental cues ultimately lead to HSC spec-
ification. A similar signaling requirement
that specifies cell fate choices—long after
the signals themselves were active—was
recently shown for BMP in the in vitro
generation of blood cells from ESCs
(Chiang and Wong, 2011). Molecular
programs that propagate over time by
either non-cell-autonomous relay signal-
ing or cell-intrinsic deterministic mecha-
nisms are not only highly interesting as
models for molecular regulation. In com-
bination with the required timed presence
of many different cell types and their
inductive signaling, they can also offer
an explanation for the remaining difficulty
in inducing HSCs from pluripotent cells
(Cerdan and Bhatia, 2010). Hopefully,
these novel insights will contribute to the
comprehensive understanding of the re-
quired combinatorial timed signals (Ciau-
Uitz et al., 2010) that will allow the efficient
generation of unlimited, well-defined, and
clinically applicable HSCs in vitro.er Inc.REFERENCES
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Myc/Max complexes are thought to be essential for maintaining pluripotency and self-renewal of embryonic
stem cells (ESCs). In this issue of Cell Stem Cell, Hishida et al. (2011) provide genetic evidence that this
requirement can be bypassed in well-defined culture conditions.Due to its pervasive involvement in human
tumorigenesis, the Myc oncoprotein and
two of its cousins, N-Myc and L-Myc,
have been under intense scrutiny for
many years. More recently, endogenous
c- and N-Myc proteins have been demon-
strated to be individually or collectively
essential for the self-renewal of embry-
onic and adult (e.g., hematopoietic) stem
cells (Smith and Dalton, 2010). Impor-tantly, deregulated expression of Myc,
as is the hallmark of many human tumors,
enhances the formation of induced plurip-
otent stem cells (iPSCs), suggesting that
the oncogenic functions of Myc may be
mechanistically related to its ability to
confer self-renewal capacity to differenti-
ated cells given the right genetic context
(Takahashi and Yamanaka, 2006). As a
result, the biochemical analysis of Mycfunction, particularly in ESCs, has begun
to set paradigms for the study of Myc in
human tumors.
Myc has an essential role in maintaining
ESCs in a proliferative, self-renewing, and
undifferentiated state. Together with a
set of interacting proteins, Myc binds to
a large set of promoters that are distinct
from promoters bound by other factors
involved in maintaining the pluripotency
